Article Data

  • Views 299
  • Dowloads 124


Open Access

Individualized management objectives for hypoxic-ischemic brain injury after cardiac arrest

  • Ying Feng1
  • Xiaohua Zhang1
  • Bo Sun1
  • Minli Li1,*,

1Department of Gastroenterology, Nanjing Medical University, Jinling Hospital, 210002 Nanjing, Jiangsu, China

DOI: 10.22514/sv.2022.051

Submitted: 22 January 2022 Accepted: 07 May 2022

Online publish date: 14 July 2022

*Corresponding Author(s): Minli Li E-mail:


Hypoxic-ischemic brain injury after cardiac arrest is the main cause of death and neurologic dysfunction in patients after the return of spontaneous circulation. The mechanisms of ischemic and hypoxic brain injury include hypoxia of brain tissue caused by the cessation of cerebral blood flow during the initial cardiac arrest and cerebrovascular dysfunction and reperfusion injury after the recovery of circulation. Cerebral circulatory perfusion, cerebral autoregulation, and cerebral edema can be monitored and controlled as therapeutic targets. In this study, from the aspects of body temperature, mean arterial pressure, oxygen concentration, partial pressure of carbon dioxide in the artery, and cerebral edema, monitoring methods such as measurement of cerebral oxygen saturation, assessment of cerebral blood flow, imaging of the brain, and measurement of intracranial pressure were introduced to explore individual management objectives for hypoxic-ischemic brain injury.


Cardiac arrest; Hypoxic-ischemic brain injury; Individual management; Cerebral monitoring

Cite and Share

Ying Feng,Xiaohua Zhang,Bo Sun,Minli Li. Individualized management objectives for hypoxic-ischemic brain injury after cardiac arrest. Signa Vitae. 2022.doi:10.22514/sv.2022.051.


[1] Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, et al. Heart disease and stroke statistics—2018 update: a report from the American Heart Association. Circulation. 2018; 137: e67–e492.

[2] Zhang S. Sudden cardiac death in China: current status and future perspectives. EP Europace. 2015; 17: ii14–ii18.

[3] Laver S, Farrow C, Turner D, Nolan J. Mode of death after admission to an intensive care unit following cardiac arrest. Intensive Care Medicine. 2004; 30: 2126–2128.

[4] Naber D, Bullinger M. Psychiatric sequelae of cardiac arrest. Dialogues in Clinical Neuroscience. 2018; 20: 73–77.

[5] Wilder Schaaf KP, Artman LK, Peberdy MA, Walker WC, Ornato JP, Gossip MR, et al. Anxiety, depression, and PTSD following cardiac arrest: a systematic review of the literature. Resuscitation. 2013; 84: 873–877.

[6] Lim GB. Cardiac resuscitation: benefit of bystander CPR and defibrilla-tion. Nature Reviews Cardiology. 2017; 14: 382.

[7] Gold LS, Fahrenbruch CE, Rea TD, Eisenberg MS. The relationship between time to arrival of emergency medical services (EMS) and survival from out-of-hospital ventricular fibrillation cardiac arrest. Resuscitation. 2010; 81: 622–625.

[8] Reis C, Akyol O, Araujo C, Huang L, Enkhjargal B, Malaguit J, et al. Pathophysiology and the monitoring methods for cardiac arrest associated brain injury. International Journal of Molecular Sciences. 2017; 18: 129.

[9] Bray JE, Hein C, Smith K, Stephenson M, Grantham H, Finn J, et al. Oxygen titration after resuscitation from out-of-hospital cardiac arrest: a multi-centre, randomised controlled pilot study (the exact pilot trial). Resuscitation. 2018; 128: 211–215.

[10] Donnino MW, Andersen LW, Berg KM, Reynolds JC, Nolan JP, Morley PT, et al. Temperature management after cardiac arrest: an advisory statement by the advanced life support task force of the International Liaison Committee on Resuscitation and the American Heart Association Emergency Cardiovascular Care Committee and the Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation. Resuscitation. 2016; 98: 97–104.

[11] Sekhon MS, Gooderham P, Menon DK, Brasher PMA, Foster D, Cardim D, et al. The burden of brain hypoxia and optimal mean arterial pressure in patients with hypoxic ischemic brain injury after cardiac arrest. Critical Care Medicine. 2019; 47: 960–969.

[12] Hope Kilgannon J, Hunter BR, Puskarich MA, Shea L, Fuller BM, Jones C, et al. Partial pressure of arterial carbon dioxide after resuscitation from cardiac arrest and neurological outcome: a prospective multi-center protocol-directed cohort study. Resuscitation. 2019; 135: 212–220.

[13] Eleff SM, Maruki Y, Monsein LH, Traystman RJ, Bryan RN, Koehler RC. Sodium, ATP, and intracellular pH transients during reversible complete ischemia of dog cerebrum. Stroke. 1991; 22: 233–241.

[14] Nishijima MK, Koehler RC, Hurn PD, Eleff SM, Norris S, Jacobus WE, et al. Postischemic recovery rate of cerebral ATP, phosphocreatine, pH, and evoked potentials. American Journal of Physiology-Heart and Circulatory Physiology. 1989; 257: H1860–H1870.

[15] Hoxworth JM, Xu K, Zhou Y, Lust WD, LaManna JC. Cerebral metabolic profile, selective neuron loss, and survival of acute and chronic hyperglycemic rats following cardiac arrest and resuscitation. Brain Research. 1999; 821: 467–479.

[16] Hansen AJ. Effect of anoxia on ion distribution in the brain. Physiological Reviews. 1985; 65: 101–148.

[17] Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 1997; 275: 1132–1136.

[18] Piantadosi CA, Zhang J. Mitochondrial generation of reactive oxygen species after brain ischemia in the rat. Stroke. 1996; 27: 327–332.

[19] Siesjö BK, Zhao Q, Pahlmark K, Siesjö P, Katsura K, Folbergrová J. Glutamate, calcium, and free radicals as mediators of ischemic brain damage. The Annals of Thoracic Surgery. 1995; 59: 1316–1320.

[20] Lau A, Tymianski M. Glutamate receptors, neurotoxicity and neurode-generation. PflüGers Archiv-European Journal of Physiology. 2010; 460: 525–542.

[21] Meldrum BS. Glutamate as a neurotransmitter in the brain: review of physiology and pathology. The Journal of Nutrition. 2000; 130: 1007S–1015S.

[22] Bro-Jeppesen J, Johansson PI, Hassager C, Wanscher M, Ostrowski SR, Bjerre M, et al. Endothelial activation/injury and associations with severity of post-cardiac arrest syndrome and mortality after out-of-hospital cardiac arrest. Resuscitation. 2016; 107: 71–79.

[23] Sundgreen C, Larsen FS, Herzog TM, Knudsen GM, Boesgaard S, Aldershvile J. Autoregulation of cerebral blood flow in patients resuscitated from cardiac arrest. Stroke. 2001; 32: 128–132.

[24] Böttiger BW, Krumnikl JJ, Gass P, Schmitz B, Motsch J, Martin E. The cerebral ‘no-reflow’ phenomenon after cardiac arrest in rats—influence of low-flow reperfusion. Resuscitation. 1997; 34: 79–87.

[25] Wu M, Yiang G, Liao W, Tsai A, Cheng Y, Cheng P, et al. Current mechanistic concepts in ischemia and reperfusion injury. Cellular Physiology and Biochemistry. 2018; 46: 1650–1667.

[26] Madathil RJ, Hira RS, Stoeckl M, Sterz F, Elrod JB, Nichol G. Ischemia reperfusion injury as a modifiable therapeutic target for cardioprotection or neuroprotection in patients undergoing cardiopulmonary resuscitation. Resuscitation. 2016; 105: 85–91.

[27] Smith M. Cerebral perfusion pressure. British Journal of Anaesthesia. 2015; 115: 488–490.

[28] Strandgaard S, Paulson OB. Cerebral autoregulation. Stroke. 1984; 15: 413–416.

[29] van den Brule JMD, van der Hoeven JG, Hoedemaekers CWE. Cerebral perfusion and cerebral autoregulation after cardiac arrest. BioMed Research International. 2018; 2018: 1–5.

[30] Lu Y, Li C, Chen Q, Liu P, Guo Q, Zhang Y, et al. Microthrombus-targeting micelles for neurovascular remodeling and enhanced microcir-culatory perfusion in acute ischemic stroke. Advanced Materials. 2019; 31: e1808361.

[31] Lee JK, Brady KM, Mytar JO, Kibler KK, Carter EL, Hirsch KG, et al. Cerebral blood flow and cerebrovascular autoregulation in a swine model of pediatric cardiac arrest and hypothermia. Critical Care Medicine. 2011; 39: 2337–2345.

[32] Bisschops LLA, Hoedemaekers CWE, Simons KS, van der Hoeven JG. Preserved metabolic coupling and cerebrovascular reactivity during mild hypothermia after cardiac arrest. Critical Care Medicine. 2010; 38: 1542–1547.

[33] Nishizawa H, Kudoh I. Cerebral autoregulation is impaired in patients resuscitated after cardiac arrest. Acta Anaesthesiologica Scandinavica. 1996; 40: 1149–1153.

[34] Storm C, Leithner C, Krannich A, Wutzler A, Ploner CJ, Trenkmann L, et al. Regional cerebral oxygen saturation after cardiac arrest in 60 patients—a prospective outcome study. Resuscitation. 2014; 85: 1037–1041.

[35] Pham P, Bindra J, Chuan A, Jaeger M, Aneman A. Are changes in cerebrovascular autoregulation following cardiac arrest associated with neurological outcome? Results of a pilot study. Resuscitation. 2015; 96: 192–198.

[36] Rud J, May TL, Riker RR, Seder DB. Early cerebral edema after cardiac arrest and its ramifications. Resuscitation. 2020; 154: 112–114.

[37] Hayman EG, Patel AP, Kimberly WT, Sheth KN, Simard JM. Cerebral edema after cardiopulmonary resuscitation: a therapeutic target following cardiac arrest? Neurocritical Care. 2018; 28: 276–287.

[38] Stokum JA, Gerzanich V, Simard JM. Molecular pathophysiology of cerebral edema. Journal of Cerebral Blood Flow & Metabolism. 2016; 36: 513–538.

[39] Simard JM, Kent TA, Chen M, Tarasov KV, Gerzanich V. Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications. The Lancet Neurology. 2007; 6: 258–268.

[40] Papadopoulos MC, Verkman AS. Aquaporin water channels in the nervous system. Nature Reviews Neuroscience. 2013; 14: 265–277.

[41] Manley GT, Fujimura M, Ma T, Noshita N, Filiz F, Bollen AW, et al. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nature Medicine. 2000; 6: 159–163.

[42] Mamtilahun M, Tang G, Zhang Z, Wang Y, Tang Y, Yang G. Targeting water in the brain: role of aquaporin-4 in ischemic brain edema. Current Drug Targets. 2019; 20: 748–755.

[43] Li X, Zhang X, Zhang C, Wang L, Li Y, Zhang Y, et al. Ulinastatin protects brain against cerebral ischemia/reperfusion injury through inhibiting MMP-9 and alleviating loss of ZO-1 and occludin proteins in mice. Experimental Neurology. 2018; 302: 68–74.

[44] Geng Y, Li E, Mu Q, Zhang Y, Wei X, Li H, et al. Hydrogen sulfide inhalation decreases early blood-brain barrier permeability and brain edema induced by cardiac arrest and resuscitation. Journal of Cerebral Blood Flow & Metabolism. 2015; 35: 494–500.

[45] Luo Z, Ovcjak A, Wong R, Yang B, Feng Z, Sun H. Drug development in targeting ion channels for brain edema. Acta Pharmacologica Sinica. 2020; 41: 1272–1288.

[46] Woo SK, Tsymbalyuk N, Tsymbalyuk O, Lvanova S, Gerzanich V, Simard JM. SUR1-TRPM4 channels, not K_AT P , mediate brain swelling following cerebral ischemia. Neuroscience Letters. 2020; 718: 134729.

[47] Polderman KH. Mechanisms of action, physiological effects, and complications of hypothermia. Critical Care Medicine. 2009; 37: S186–S202.

[48] Polderman KH. Induced hypothermia and fever control for prevention and treatment of neurological injuries. The Lancet. 2008; 371: 1955–1969.

[49] Abella BS, Zhao D, Alvarado J, Hamann K, Vanden Hoek TL, Becker LB. Intra-arrest cooling improves outcomes in a murine cardiac arrest model. Circulation. 2004; 109: 2786–2791.

[50] Kuboyama K, Safar P, Radovsky A, Tisherman SA, Stezoski SW, Alexander H. Delay in cooling negates the beneficial effect of mild resuscitative cerebral hypothermia after cardiac arrest in dogs: a prospective, randomized study. Critical Care Medicine. 1993; 21: 1348–1358.

[51] Che D, Li L, Kopil CM, Liu Z, Guo W, Neumar RW. Impact of therapeutic hypothermia onset and duration on survival, neurologic function, and neurodegeneration after cardiac arrest. Critical Care Medicine. 2011; 39: 1423–1430.

[52] Iordanova B, Li L, Clark RSB, Manole MD. Alterations in cerebral blood flow after resuscitation from cardiac arrest. Frontiers in Pediatrics. 2017; 5: 174.

[53] Mooney MR, Unger BT, Boland LL, Burke MN, Kebed KY, Graham KJ, et al. Therapeutic hypothermia after out-of-hospital cardiac arrest: evaluation of a regional system to increase access to cooling. Circulation. 2011; 124: 206–214.

[54] Sendelbach S, Hearst MO, Johnson PJ, Unger BT, Mooney MR. Effects of variation in temperature management on cerebral performance category scores in patients who received therapeutic hypothermia post cardiac arrest. Resuscitation. 2012; 83: 829–834.

[55] Haugk M, Testori C, Sterz F, Uranitsch M, Holzer M, Behringer W, et al. Relationship between time to target temperature and outcome in patients treated with therapeutic hypothermia after cardiac arrest. Critical Care. 2011; 15: R101.

[56] Scolletta S, Taccone F, Nordberg P, Donadello K, Vincent J, Castren M. Intra-arrest hypothermia during cardiac arrest: a systematic review. Critical Care. 2012; 16: R41.

[57] Bernard SA, Smith K, Cameron P, Masci K, Taylor DM, Cooper DJ, et al. Induction of therapeutic hypothermia by paramedics after resuscitation from out-of-hospital ventricular fibrillation cardiac arrest: a randomized controlled trial. Circulation. 2010; 122: 737–742.

[58] Kim F, Nichol G, Maynard C, Hallstrom A, Kudenchuk PJ, Rea T, et al. Effect of prehospital induction of mild hypothermia on survival and neurological status among adults with cardiac arrest: a randomized clinical trial. JAMA. 2014; 311: 45.

[59] Lindsay PJ, Buell D, Scales DC. The efficacy and safety of pre-hospital cooling after out-of-hospital cardiac arrest: a systematic review and meta-analysis. Critical Care. 2018; 22: 66.

[60] Awad A, Taccone FS, Jonsson M, Forsberg S, Hollenberg J, Truhlar A, et al. Time to intra-arrest therapeutic hypothermia in out-of-hospital cardiac arrest patients and its association with neurologic outcome: a propensity matched sub-analysis of the PRINCESS trial. Intensive Care Medicine. 2020; 46: 1361–1370.

[61] Nordberg P, Taccone FS, Truhlar A, Forsberg S, Hollenberg J, Jonsson M, et al. Effect of trans-nasal evaporative intra-arrest cooling on functional neurologic outcome in out-of-hospital cardiac arrest. JAMA. 2019; 321: 1677.

[62] Scales DC, Cheskes S, Verbeek PR, Pinto R, Austin D, Brooks SC, et al. Prehospital cooling to improve successful targeted temperature man-agement after cardiac arrest: a randomized controlled trial. Resuscitation. 2017; 121: 187–194.

[63] Callaway CW, Donnino MW, Fink EL, Geocadin RG, Golan E, Kern KB, et al. Part 8: post-cardiac arrest care: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2015; 132: S465–S482.

[64] Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. New England Journal of Medicine. 2002; 346: 557–563.

[65] Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. The New England Journal of Medicine. 2002; 346: 549–556.

[66] Nielsen N, Wetterslev J, Cronberg T, Erlinge D, Gasche Y, Hassager C, et al. Targeted temperature management at 33 ◦C versus 36 ◦C after cardiac arrest. New England Journal of Medicine. 2013; 369: 2197–2206.

[67] Alqalyoobi S, Boctor N, Sarkeshik AA, Hoerger J, Klimberg N, Bartolome BG, et al. Therapeutic hypothermia and mortality in the intensive care unit: systematic review and meta-analysis. Critical Care and Resuscitation: Journal of the Australasian Academy of Critical Care Medicine. 2019; 21: 287–298.

[68] Kalra R, Arora G, Patel N, Doshi R, Berra L, Arora P, et al. Targeted temperature management after cardiac arrest: systematic review and meta-analyses. Anesthesia & Analgesia. 2018; 126: 867–875.

[69] Fernando SM, Di Santo P, Sadeghirad B, Lascarrou J, Rochwerg B, Mathew R, et al. Targeted temperature management following out-of-hospital cardiac arrest: a systematic review and network meta-analysis of temperature targets. Intensive Care Medicine. 2021; 47: 1078–1088.

[70] Stanger D, Mihajlovic V, Singer J, Desai S, El-Sayegh R, Wong GC. Editor’s choice-effects of targeted temperature management on mortality and neurological outcome: a systematic review and meta-analysis. European Heart Journal: Acute Cardiovascular Care. 2018; 7: 467–477.

[71] Shinozaki K, Oda S, Sadahiro T, Nakamura M, Hirayama Y, Watanabe E, et al. Duration of well-controlled core temperature correlates with neurological outcome in patients with post-cardiac arrest syndrome. The American Journal of Emergency Medicine. 2012; 30: 1838–1844.

[72] Kagawa E, Dote K, Kato M, Sasaki S, Oda N, Nakano Y, et al. Do lower target temperatures or prolonged cooling provide improved outcomes for comatose survivors of cardiac arrest treated with hypothermia? Journal of the American Heart Association. 2015; 4: e002123.

[73] Kirkegaard H, Søreide E, de Haas I, Pettilä V, Taccone FS, Arus U, et al. Targeted temperature management for 48 vs. 24 hours and neurologic outcome after out-of-hospital cardiac arrest: a randomized clinical trial. JAMA. 2017; 318: 341–350.

[74] Pittl U, Schratter A, Desch S, Diosteanu R, Lehmann D, Demmin K, et al. Invasive versus non-invasive cooling after in- and out-of-hospital cardiac arrest: a randomized trial. Clinical Research in Cardiology. 2013; 102: 607–614.

[75] Deye N, Cariou A, Girardie P, Pichon N, Megarbane B, Midez P, et al. Endovascular versus external targeted temperature management for patients with out-of-hospital cardiac arrest: a randomized, controlled study. Circulation. 2015; 132: 182–193.

[76] Busch H-, Eichwede F, Födisch M, Taccone FS, Wöbker G, Schwab T, et al. Safety and feasibility of nasopharyngeal evaporative cooling in the emergency department setting in survivors of cardiac arrest. Resuscitation. 2010; 81: 943–949.

[77] Castrén M, Nordberg P, Svensson L, Taccone F, Vincent J, Desruelles D, et al. Intra-arrest transnasal evaporative cooling: a randomized, prehospital, multicenter study (PRINCE: Pre-ROSC intranasal cooling effectiveness). Circulation. 2010; 122: 729–736.

[78] Deakin CD, Nolan JP, Soar J, Sunde K, Koster RW, Smith GB, et al. European resuscitation council guidelines for resuscitation 2010 section 4. Adult advanced life support. Resuscitation. 2010; 81: 1305–1352.

[79] Bouwes A, Robillard LBM, Binnekade JM, de Pont AJM, Wieske L, Hartog AWD, et al. The influence of rewarming after therapeutic hypothermia on outcome after cardiac arrest. Resuscitation. 2012; 83: 996–1000.

[80] Hifumi T, Inoue A, Kokubu N, Hase M, Yonemoto N, Kuroda Y, et al. Association between rewarming duration and neurological outcome in out-of-hospital cardiac arrest patients receiving therapeutic hypothermia. Resuscitation. 2020; 146: 170–177.

[81] Hunter BR, Ellender TJ. Targeted temperature management in emergency medicine: current perspectives. Open Access Emergency Medicine. 2015; 7: 69–77.

[82] Nielsen N, Sunde K, Hovdenes J, Riker RR, Rubertsson S, Stammet P, et al. Adverse events and their relation to mortality in out-of-hospital cardiac arrest patients treated with therapeutic hypothermia. Critical Care Medicine. 2011; 39: 57–64.

[83] Badjatia N, Strongilis E, Prescutti M, Fernandez L, Fernandez A, Buitrago M, et al. Metabolic benefits of surface counter warming during therapeutic temperature modulation. Critical Care Medicine. 2009; 37: 1893–1897.

[84] Cheng C, Matsukawa T, Sessler DI, Ozaki M, Kurz A, Merrifield B, et al. Increasing mean skin temperature linearly reduces the core-temperature thresholds for vasoconstriction and shivering in humans. Anesthesiology. 1995; 82: 1160–1168.

[85] Logan A, Sangkachand P, Funk M. Optimal management of shivering during therapeutic hypothermia after cardiac arrest. Critical Care Nurse. 2011; 31: e18–e30.

[86] Bhate TD, McDonald B, Sekhon MS, Griesdale DEG. Association between blood pressure and outcomes in patients after cardiac arrest: a systematic review. Resuscitation. 2015; 97: 1–6.

[87] Brady KM, Lee JK, Kibler KK, Smielewski P, Czosnyka M, Easley RB, et al. Continuous time-domain analysis of cerebrovascular autoregulation using near-infrared spectroscopy. Stroke. 2007; 38: 2818–2825.

[88] Sekhon MS, Smielewski P, Bhate TD, Brasher PM, Foster D, Menon DK, et al. Using the relationship between brain tissue regional saturation of oxygen and mean arterial pressure to determine the optimal mean arterial pressure in patients following cardiac arrest: a pilot proof-of-concept study. Resuscitation. 2016; 106: 120–125.

[89] Hoiland RL, Sekhon MS, Cardim D, Wood MD, Gooderham P, Foster D, et al. Lack of agreement between optimal mean arterial pressure determination using pressure reactivity index versus cerebral oximetry index in hypoxic ischemic brain injury after cardiac arrest. Resuscitation. 2020; 152: 184–191.

[90] Rikhraj KJK, Wood MD, Hoiland RL, Thiara S, Griesdale DEG, Sekhon MS. Determining optimal mean arterial pressure after cardiac arrest: a systematic review. Neurocritical Care. 2021; 34: 621–634.

[91] Dell’Anna AM, Lamanna I, Vincent J, Taccone FS. How much oxygen in adult cardiac arrest? Critical Care. 2014; 18: 555.

[92] Yamamoto R, Yoshizawa J. Oxygen administration in patients recovering from cardiac arrest: a narrative review. Journal of Intensive Care. 2020; 8: 60.

[93] Brugniaux JV, Coombs GB, Barak OF, Dujic Z, Sekhon MS, Ainslie PN. Highs and lows of hyperoxia: physiological, performance, and clinical aspects. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 2018; 315: R1–R27.

[94] Tuder RM, Hunt JM, Schmidt EP. Hyperoxia and apoptosis. Too much of a good thing? American Journal of Respiratory and Critical Care Medicine. 2011; 183: 964–965.

[95] Pilcher J, Weatherall M, Shirtcliffe P, Bellomo R, Young P, Beasley R. The effect of hyperoxia following cardiac arrest—a systematic review and meta-analysis of animal trials. Resuscitation. 2012; 83: 417–422.

[96] Kilgannon JH, Jones AE, Shapiro NI, Angelos MG, Milcarek B, Hunter K. Association between arterial hyperoxia following resuscitation from cardiac arrest and in-hospital mortality. JAMA. 2010; 303: 2165–2171.

[97] Wang C, Chang W, Huang C, Tsai M, Yu P, Wang A, et al. The effect of hyperoxia on survival following adult cardiac arrest: a systematic review and meta-analysis of observational studies. Resuscitation. 2014; 85: 1142–1148.

[98] Patel JK, Kataya A, Parikh PB. Association between intra- and post-arrest hyperoxia on mortality in adults with cardiac arrest: a systematic review and meta-analysis. Resuscitation. 2018; 127: 83–88.

[99] Roberts BW, Kilgannon JH, Hunter BR, Puskarich MA, Pierce L, Donnino M, et al. Association between early hyperoxia exposure after resuscitation from cardiac arrest and neurological disability: prospective multicenter protocol-directed cohort study. Circulation. 2018; 137: 2114–2124.

[100] Bellomo R, Bailey M, Eastwood GM, Nichol A, Pilcher D, Hart GK, et al. Arterial hyperoxia and in-hospital mortality after resuscitation from cardiac arrest. Critical Care. 2011; 15: R90.

[101] Oh YT, Kim YH, Sohn YD, Park SE, Shin DH, Hwang SY, et al. Early hyperoxemia may not increase mortality after cardiac arrest: a pilot study. Clinical and Experimental Emergency Medicine. 2014; 1: 28–34.

[102] Vaahersalo J, Bendel S, Reinikainen M, Kurola J, Tiainen M, Raj R, et al. Arterial blood gas tensions after resuscitation from out-of-hospital cardiac arrest: associations with long-term neurologic outcome. Critical Care Medicine. 2014; 42: 1463–1470.

[103] Thomas M, Voss S, Benger J, Kirby K, Nolan JP. Cluster randomised comparison of the effectiveness of 100

[104] Roberts BW, Kilgannon JH, Chansky ME, Mittal N, Wooden J, Trzeciak S. Association between postresuscitation partial pressure of arterial carbon dioxide and neurological outcome in patients with post-cardiac arrest syndrome. Circulation. 2013; 127: 2107–2113.

[105] Brian J. Carbon dioxide and the cerebral circulation. Anesthesiology. 1998; 88: 1365–1386.

[106] Eastwood GM, Schneider AG, Suzuki S, Peck L, Young H, Tanaka A, et al. Targeted therapeutic mild hypercapnia after cardiac arrest: a phase II multi-centre randomised controlled trial (the CCC trial). Resuscitation. 2016; 104: 83–90.

[107] Eastwood GM, Tanaka A, Bellomo R. Cerebral oxygenation in mechanically ventilated early cardiac arrest survivors: the impact of hypercapnia. Resuscitation. 2016; 102: 11–16.

[108] Schneider AG, Eastwood GM, Bellomo R, Bailey M, Lipcsey M, Pilcher D, et al. Arterial carbon dioxide tension and outcome in patients admitted to the intensive care unit after cardiac arrest. Resuscitation. 2013; 84: 927–934.

[109] Wang HE, Prince DK, Drennan IR, Grunau B, Carlbom DJ, Johnson N, et al. Post-resuscitation arterial oxygen and carbon dioxide and outcomes after out-of-hospital cardiac arrest. Resuscitation. 2017; 120: 113–118.

[110] McKenzie N, Williams TA, Tohira H, Ho KM, Finn J. A systematic review and meta-analysis of the association between arterial carbon dioxide tension and outcomes after cardiac arrest. Resuscitation. 2017; 111: 116–126.

[111] Jakkula P, Reinikainen M, Hästbacka J, Loisa P, Tiainen M, Pettilä V, et al. Targeting two different levels of both arterial carbon dioxide and arterial oxygen after cardiac arrest and resuscitation: a randomised pilot trial. Intensive Care Medicine. 2018; 44: 2112–2121.

[112] Skrifvars MB, Olasveengen TM, Ristagno G. Oxygen and carbon dioxide targets during and after resuscitation of cardiac arrest patients. Intensive Care Medicine. 2019; 45: 284–286.

[113] Keijzer HM, Hoedemaekers CWE, Meijer FJA, Tonino BAR, Klijn CJM, Hofmeijer J. Brain imaging in comatose survivors of cardiac arrest: pathophysiological correlates and prognostic properties. Resuscitation. 2018; 133: 124–136.

[114] Kim SH, Choi SP, Park KN, Youn CS, Oh SH, Choi SM. Early brain computed tomography findings are associated with outcome in patients treated with therapeutic hypothermia after out-of-hospital cardiac arrest. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine. 2013; 21: 57.

[115] Cristia C, Ho M, Levy S, Andersen LW, Perman SM, Giberson T, et al. The association between a quantitative computed tomography (CT) measurement of cerebral edema and outcomes in post-cardiac arrest—a validation study. Resuscitation. 2014; 85: 1348–1353.

[116] Metter RB, Rittenberger JC, Guyette FX, Callaway CW. Association between a quantitative CT scan measure of brain edema and outcome after cardiac arrest. Resuscitation. 2011; 82: 1180–1185.

[117] Gutierrez LG, Rovira A, Portela LAP, Leite CDC, Lucato LT. CT and MR in non-neonatal hypoxic-ischemic encephalopathy: radiological findings with pathophysiological correlations. Neuroradiology. 2010; 52:


[118] Ryoo SM, Jeon S, Sohn CH, Ahn S, Han C, Lee BK, et al. Predicting outcome with diffusion-weighted imaging in cardiac arrest patients receiving hypothermia therapy: multicenter retrospective cohort study. Critical Care Medicine. 2015; 43: 2370–2377.

[119] Velly L, Perlbarg V, Boulier T, Adam N, Delphine S, Luyt C, et al. Use of brain diffusion tensor imaging for the prediction of long-term neurological outcomes in patients after cardiac arrest: a multicentre, international, prospective, observational, cohort study. The Lancet Neurology. 2018; 17: 317–326.

[120] Hirsch KG, Mlynash M, Eyngorn I, Pirsaheli R, Okada A, Komshian S, et al. Multi-center study of diffusion-weighted imaging in coma after cardiac arrest. Neurocritical Care. 2016; 24: 82–89.

[121] Wijman CAC, Mlynash M, Finley Caulfield A, Hsia AW, Eyngorn I, Bammer R, et al. Prognostic value of brain diffusion-weighted imaging after cardiac arrest. Annals of Neurology. 2009; 65: 394–402.

[122] Mlynash M, Campbell DM, Leproust EM, Fischbein NJ, Bammer R, Eyngorn I, et al. Temporal and spatial profile of brain diffusion-weighted mri after cardiac arrest. Stroke. 2010; 41: 1665–1672.

[123] Narayan RK, Kishore PRS, Becker DP, Ward JD, Enas GG, Greenberg RP, et al. Intracranial pressure: to monitor or not to monitor? Journal of Neurosurgery. 1982; 56: 650–659.

[124] Cocchi MN, Lucas JM, Salciccioli J, Carney E, Herman S, Zimetbaum P, et al. The role of cranial computed tomography in the immediate post-cardiac arrest period. Internal and Emergency Medicine. 2010; 5: 533–538.

[125] Morimoto Y, Kemmotsu O, Kitami K, Matsubara I, Tedo I. Acute brain swelling after out-of-hospital cardiac arrest: pathogenesis and outcome. Critical Care Medicine. 1993; 21: 104–110.

[126] Badri S, Chen J, Barber J, Temkin NR, Dikmen SS, Chesnut RM, et al. Mortality and long-term functional outcome associated with intracranial pressure after traumatic brain injury. Intensive Care Medicine. 2012; 38: 1800–1809.

[127] Kasotakis G, Michailidou M, Bramos A, Chang Y, Velmahos G, Alam H, et al. Intraparenchymal vs. extracranial ventricular drain intracranial pressure monitors in traumatic brain injury: less is more? Journal of the American College of Surgeons. 2012; 214: 950–957.

[128] Chen J, Gombart Z, Rogers S, Gardiner S, Cecil S, Bullock R. Pupillary reactivity as an early indicator of increased intracranial pressure: the introduction of the neurological pupil index. Surgical Neurology International. 2011; 2: 82.

[129] Cardim D, Schmidt B, Robba C, Donnelly J, Puppo C, Czosnyka M, et al. Transcranial doppler monitoring of intracranial pressure plateau waves. Neurocritical Care. 2017; 26: 330–338.

[130] Raffiz M, Abdullah JM. Optic nerve sheath diameter measurement: a means of detecting raised ICP in adult traumatic and non-traumatic neurosurgical patients. The American Journal of Emergency Medicine. 2017; 35: 150–153.

[131] Cardim D, Griesdale DE, Ainslie PN, Robba C, Calviello L, Czosnyka M, et al. A comparison of non-invasive versus invasive measures of intracranial pressure in hypoxic ischaemic brain injury after cardiac arrest. Resuscitation. 2019; 137: 221–228.

[132] Robba C, Cardim D, Tajsic T, Pietersen J, Bulman M, Donnelly J, et al. Ultrasound non-invasive measurement of intracranial pressure in neurointensive care: a prospective observational study. PLoS Medicine. 2017; 14: e1002356.

[133] Nakayama S, Taguchi N, Isaka Y, Nakamura T, Tanaka M. Gliben-clamide and therapeutic hypothermia have comparable effect on at-tenuating global cerebral edema following experimental cardiac arrest. Neurocritical Care. 2018; 29: 119–127.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

IndexCopernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus: CiteScore 0.5(2021) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time